About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
Kura Oncology, Inc. (KURA): Insider Trades and Fund Holdings
In the past 12 months, Kura Oncology, Inc. insiders reported 2 open-market purchases worth $2.35M and 12 sales worth $2.54M; 6 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.
- Sep 29, 2026Insider saleChief Medical Officer Mollie Leoni sold $309,567
- Sep 29, 2026Insider saleChief Commercial Officer Brian T. Powl sold $165,852
- Sep 29, 2026Insider saleCOO Kathleen Ford sold $39,437 under a 10b5-1 plan
- Sep 29, 2026Planned saleMOLLIE LEONI (officer) filed notice to sell about $305,589 around Sep 29, 2026
- Sep 29, 2026Planned saleBRIAN POWL (officer) filed notice to sell about $163,712 around Sep 29, 2026
- Sep 29, 2026Planned saleKATHLEEN FORD (officer) filed notice to sell about $38,917 around Sep 29, 2026
- Sep 28, 2026Insider saleChief Commercial Officer Brian T. Powl sold $179,184
- Sep 28, 2026Insider saleChief Medical Officer Mollie Leoni sold $130,670
- Sep 28, 2026Insider saleGeneral Counsel Teresa Brophy Bair sold $88,618 under a 10b5-1 plan
- Sep 28, 2026Insider saleCOO Kathleen Ford sold $72,494 under a 10b5-1 plan
- Sep 28, 2026Insider saleSVP Thomas James Doyle sold $48,361
- Sep 28, 2026Planned saleLEONI MOLLIE (officer) filed notice to sell about $133,940 around Sep 28, 2026
- Sep 28, 2026Planned salePOWL BRIAN T (officer) filed notice to sell about $97,055 around Sep 28, 2026
- Sep 28, 2026Planned saleBAIR TERESA BROPHY (officer) filed notice to sell about $90,836 around Sep 28, 2026
- Sep 28, 2026Planned saleBRIAN POWL (officer) filed notice to sell about $86,080 around Sep 28, 2026
- Sep 28, 2026Planned saleFORD KATHLEEN (officer) filed notice to sell about $74,309 around Sep 28, 2026
- Sep 28, 2026Planned saleDOYLE THOMAS JAMES (officer) filed notice to sell about $49,571 around Sep 28, 2026
- Sep 24, 2026Insider saleChief Scientific Officer Francis Burrows sold $224,514
- Sep 24, 2026Planned saleFRANCIS J BURROWS (officer) filed notice to sell about $224,514 around Sep 24, 2026
- Sep 8, 2026NewsCompany reported: Executive or director change
- Aug 24, 2026Insider buyCEO Troy Edward Wilson bought $1.2 million
- Aug 21, 2026Insider saleChief Commercial Officer Brian T. Powl sold $51,663 under a 10b5-1 plan (9 days after: quarterly or annual results)
- Aug 21, 2026Planned saleBRIAN POWL (officer) filed notice to sell about $50,880 around Aug 21, 2026
- Aug 19, 2026Insider saleGeneral Counsel Teresa Brophy Bair sold $397,681 under a 10b5-1 plan (7 days after: quarterly or annual results)
- Aug 19, 2026Planned saleTERESA BAIR (officer) filed notice to sell about $388,235 around Aug 19, 2026
- Aug 17, 2026Insider buyCEO Troy Edward Wilson bought $1.1 million (5 days after: quarterly or annual results)
- Aug 12, 2026NewsCompany reported: Quarterly or annual results
- Jul 29, 2026NewsCompany reported: Executive or director change
- Jun 30, 2026FundRenaissance Technologies added 5% in Q2 2026 (13F filed Aug 13, 2026)
- Jun 18, 2026Insider saleChief Medical Officer Mollie Leoni sold $834,283 under a 10b5-1 plan
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 29, 2026.
| Filed | Insider | Type | Value | Score |
|---|---|---|---|---|
| Sep 29 | Mollie LeoniChief Medical Officer | ▼ SELL | $310K | |
| Sep 29 | Brian T. PowlChief Commercial Officer | ▼ SELL | $179K | |
| Sep 29 | Brian T. PowlChief Commercial Officer | ▼ SELL | $166K | |
| Sep 29 | Mollie LeoniChief Medical Officer | ▼ SELL | $131K | |
| Sep 29 | Teresa Brophy BairGeneral Counsel | ▼ SELL10b5-1 | $89K | |
| Sep 29 | Kathleen FordCOO | ▼ SELL10b5-1 | $72K | |
| Sep 29 | Thomas James DoyleSVP | ▼ SELL | $48K | |
| Sep 29 | Kathleen FordCOO | ▼ SELL10b5-1 | $39K | |
| Sep 25 | Francis BurrowsChief Scientific Officer | ▼ SELL | $225K | |
| Aug 24 | Troy Edward WilsonCEO | ▲ BUY | $1.24M | 47 |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Mollie Leoni | Chief Medical Officer | 0 | $0 | 3 | $1.27M |
| Brian T. Powl | Chief Commercial Officer | 0 | $0 | 3 | $397K |
| Teresa Brophy Bair | General Counsel | 0 | $0 | 2 | $486K |
| Kathleen Ford | COO | 0 | $0 | 2 | $112K |
| Thomas James Doyle | SVP | 0 | $0 | 1 | $48K |
| Francis Burrows | Chief Scientific Officer | 0 | $0 | 1 | $225K |
| Troy Edward Wilson | CEO | 2 | $2.35M | 0 | $0 |
Buybacks and executive pay
| Year | CEO pay reported | CEO pay "actually paid" | Value of $100 invested |
|---|---|---|---|
| 2025 | $4.74M | $6.49M | n/a |
| 2024 | $6.24M | $4.23M | n/a |
| 2023 | $5.25M | $5.95M | n/a |
From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.
47 Troy Edward Wilson (CEO), 2026-08-24. What the score means
A All 14 insider trades reported on time. How it is graded
Tracked funds that report KURA
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 1,663,765 | $18.3M | ▲ +5.1% |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →